Troy Groetken Quoted in Outsourced Pharma Article About the COVID-19 IP Waiver


He discusses the potential impact of the waiver, provides insights into patent-sharing pledges already in place, and suggests how companies can best be incentivized to continue innovating and developing products.

To read the full article, click here.